# DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia

> **NCT02103673** · PHASE2 · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 90 (actual)

## Conditions studied

- Behavioral and Psychological Symptoms in Alzheimer's Disease
- Behavioral and Psychological Symptoms in Vascular Dementia

## Interventions

- **DRUG:** DAOIB
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02103673
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2018-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02103673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02103673, "DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02103673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*